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Abstract
Background: We retrospectively reviewed magnetic resonance (MR) images of 96 patients with diagnosis of rectal
cancer to evaluate tumour stage (T stage), involvement of mesorectal fascia (MRF), and nodal metastasis (N stage).
Our gold standard was histopathology.
Methods: All studies were performed with 1.5-T MR system (Symphony; Siemens Medical System, Erlangen,
Germany) by using a phased-array coil. Our population was subdivided into two groups: the first one, formed by
patients at T1-T2-T3, N0, M0 stage, whose underwent MR before surgery; the second group included patients at Tx
N1 M0 and T3-T4 Nx M0 stage, whose underwent preoperative MR before neoadjuvant chemoradiation therapy
and again 4-6 wks after the end of the treatment for the re-staging of disease.
Our gold standard was histopathology.
Results: MR showed 81% overall agreement with histological findings for T and N stage prediction; for T stage,
this rate increased up to 95% for pts of group I (48/96), while for group II (48/96) it decreased to 75%.
Preoperative MR prediction of histologically involved MRF resulted very accurate (sensitivity 100%; specificity 100%)
also after chemoradiation (sensitivity 100%; specificity 67%).
Conclusions: Phased-array MRI was able to clearly estimate the entire mesorectal fat and surrounding pelvic
structures resulting the ideal technique for local preoperative rectal cancer staging.
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Introduction
Rectal cancer is one of the most common tumour in
Europe and in the United States (40 cases in every
100,000 individuals) [1] with a poor prognosis caused by
high risk of local recurrence and metastasis. The local
recurrence is related to the extramural tumour spread
into the mesorectum and to the tumour distance from
circumferential resection margin (CRM). Imaging plays
a crucial role in the preoperative management of rectal
carcinoma because traditional techniques usually per-
formed to make diagnosis (colonoscopy and digital rec-
tal examination), do not adequately show important
prognostic features such as depth of tumour spread T
stage) or the extent of lymph node involvement (N
stage) [2,3].
At the present, the experts agreed that total mesorec-
tal excision (TME) is the surgical approach of choice for
rectal cancer, because it is able to reduce the local
recurrence rate to less than 10% [4], improving the 5-
year survival rate if compared with conventional surgery
[5]. Moreover, after surgery local recurrence risk
increases if the CRM is involved from the tumour. In
selected patients with involvement of MRF at the time
of diagnosis, the use of preoperative radiation therapy is
advocated and it has been shown to further reduce the
local recurrence rate from 8.2% to 2.4% at 2 years [5,6].
Using TME as surgical approach, MRF represents the
CRM and consequently its involvement becomes the
most important prognostic factor.
Due to this, preoperative staging techniques for rectal
cancer should also distinguish patients with high risk of
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benefit from preoperative radiation therapy, from those
patients at low risk, with the tumour located far from
MRF, who might go directly to surgery. Then, it is
always necessary to pay attention to the main risk factor
for local recurrence that are: incomplete resection,
nodal disease and distal tumour.
The aim of this report is to show that crucial role of
phased-array MRI as technique of choice to preoperative
locally stage rectal cancer, since it is the only technique
able to accurately predict T and N stage and to depict
the involvement of MRF.
Materials and methods
Study population
Between June 2005 - December 2008 we retrospectively
reviewed 96 patients with histological diagnosis of rectal
cancer, performed by endoscopical evaluation. This
study population was subdivided into two groups: the
first group was characterized by patients at T1-T2-T3
N0 M0 stage, whose underwent just a single MR exami-
nation before surgery. T3 stage patients, belonging to
this group, despite the locally advanced disease, did not
underwent neoadjuvant chemoradiation therapy, due to
serious controindications to the treatment itself (such as
chronic inflammatory disease, important diverticulitis,
acute rheumatic disease, grave behaviour disease and
the impossibility to maintain the treatment position).
The second group included patients at Tx N1 M0 and
T3-T4 Nx M0 stage of disease, whose underwent MR
staging, then received neoadjuvant chemoradiation ther-
apy and finally performed a second MR for the re-sta-
ging of disease.
The lesions were considered as T1 stage tumours
when clearly limited to submucosa (Figure 1a-b) and as
T2 stage tumours when limited to the rectal wall (Figure
2). It is important to underline the not always it is possi-
ble to distinguish tumour growth limited to the submu-
cosa or the invasion to the muscolaris externa: anyway,
in these cases it is not necessary to make the always dif-
ference because both tumours are treated with TME-
surgery (only in a minority of cases a T1 tumour will be
treated with local excision and in these cases, when MR
cannot distinguish between T1 versus T2 stage, endor-
ectal US may help to identify superficial tumours).
T3 stage tumours were considered those lesions with a
growth through all wall layers and extended into the
perirectal fat tissue (Figure 3a-c) while T4 stage lesions
showed an invasion of surrounding structures like pelvic
wall, vagina, prostate, seminal vescicle or bladder (Figure
4a-b).
All MR findings were compared with histological
results.
MRI technique
MR imaging was performed with a 1.5- Siemens Medical
System, Erlangen, Germany T MR imager (Symphony;)
using a pelvic phased-array surface RF coil, necessary to
reduce patient discomfort and to obtain higher spatial
resolution images providing a full evaluation of rectal
wall layers with the additional advantage of a large field
of view.
All subjects were positioned in a supine, feet-first
position with the lower edge of the coil placed at least
10 cm below the symphysis pubis in order to ensure
adequate signal from the lower rectum and anorectal
junction.
In our experience there was no need to use the endor-
ectal coil because despite it may produce very high sig-
nal, its primary limitation is its small volume of
Figure 1 The axial T2TSEwi sequence show a small T1 lesion infiltrating the right postero-lateral rectal wall with clear invasion of
submucosa (1a) exactly correlating with the histology (1b).
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surrounding tissues to adequately stage rectal cancer. In
fact, the area that can be imaged with endorectal coil
amounts to a total distance of one coil diameter away
from it that results in a very rapid drop in signal inten-
sity beyond the immediate vicinity of the coil itself.
Moreover, as with any other endoluminal technique, ste-
nosis and stricturing, pain and discomfort, bowel wall
motion, low lesions, lesions in the upper rectum and
coil migration are all factors that hamper image
acquisition.
No purgative bowel preparation or enemas, air-insuf-
flation and contrast agents were administered. The use
of intravenous antiperistaltic agents was not necessary
to diminish movement in the small bowel since only the
tumours of the lower two-thirds of the rectum were
studied.
Multiplanar localizing images were obtained to select
transverse, coronal and sagittal images with a T2-
weighted fast spin-echo (FSE) sequence (repetition time
msec/echo time msec, 4000-6000/100; 256 × 256 matrix,
echo train length, 100-130; two signals acquired;
sequence duration 3-5 minutes). These images were
obtained with a 24-cm field of view and 4-mm-thick
sections with no intersection gap. The sagittal images
obtained were used to plan large field of view T2-
weighted axial sections of the whole pelvis, from the
iliac crest to the symphisis pubis (repetition time msec/
echo time msec, 4000-6000/100; 256 × 256 matrix, echo
Figure 2 The axial T2TSEwi sequence show a typical T2-stage
lesion infiltrating muscolaris propria but limited to the bowel
wall, which may be identified as the black line around the
tumour.
Figure 3 The axial T2TSEwi sequence demonstrates a T3-stage tumour infiltrating perirectal fat. There is a wide resection margin around
the tumour and there are no lymphnodes adjacent to the MRF as demonstrated by the histology and by the corresponding gross specimen.
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duration 3-5 minutes). While the second series was
being acquired, we again use the sagittal T2-weighted
images obtained to plan to plan high-resolution T2-
weighted thin-section axial images (repetition time
msec/echo time msec, 4000-7000/100; 256 × 256 matrix,
echo train length, 110-140; four signals acquired;
sequence duration 5-7 minutes) through the rectal
tumour and adjacent perirectal tissues. These images
were performed perpendicularly to the long-axis of the
tumour and rectal wall. The images were obtained by
using a 16-cm field of view, a 3-mm section thickness
and no intersection gap.
T1-weighted imaging (with/w i t h o u tc o n t r a s ta g e n t )
was not performed, as it contributed any additional sta-
ging information to the analysis. No fat suppression was
used to better delineate the tumour against the perirec-
tal fat.
Some patients ( < 5%), either due to co-existing medi-
cal conditions or claustrophobia, found the scan impos-
sible to tolerate. In these cases some of the sequences
were omitted. Of all sequences the oblique high-resolu-
tion scans are the most important so the sagittal views
i st h eo n l ys e q u e n c ew h i c hm a yb es h o r t e n e db ym o d i -
fying the parameters and the large field of view. In these
cases, axial T2-weighted images should be performed
last and may be omitted if the patient is in considerable
discomfort.
Adjuvant therapy
Pre-operative neo-adjuvant therapy has been shown to
improve overall survival in patient with rectal carcinoma
[5] especially when it is added to TME surgery in terms
of local control. There is a need to improve overall sur-
vival and this may be achieved by delivering systemically
active chemotherapy synchronously with pre-operative
radiation. Moreover, to protract the therapy help to
downstage rectal tumours, reducing the rate of patients
with positive CRM (CRM+). Sometimes (20% of cases)
chemoradiation therapy lead to complete destruction of
tumour cells [7].
The challenge is to identify pre-operatively patients
with high risk of local recurrence performing TME sur-
g e r ya l o n ea n dh e n c ei d e n t i f yw h om a yb e n e f i tf r o m
preoperative chemo-radiation.
In our study we used high-resolution phased-array coil
MRI to allow better selection of patients who could have
required pre-operative neo-adjuvant therapy from those
who could have be safely treated with surgery alone. 48/
96 patients underwent 5 weeks of pre-operative chemo-
radiation therapy using standard dose radiation (45 Gy
in 25 daily fractions) concurrently with systemically
effective chemotherapy.
Pre-operative MRI restaging was planned to take place
4-6 weeks after completion of neo-adjuvant therapy.
Surgery was performed within 2 weeks following this
pre-operative MRI restaging (6-8 weeks after completion
of neo-adjuvant therapy).
Specimen handlings and antomopathological technique
Good pathological reporting of rectal carcinoma is
essential if we are to achieve the optimum possible
results for patients with this tumour. There is nowadays
good evidence that survival differs dramatically between
surgeons and that the adoption of TME can improve
local recurrence rates and survival [8-11].
After TME, each resected specimen was sent to the
pathologist unopened and fresh (not in formalin). Not
opening the specimen facilitates comparison with MRI
which means an important quality control assessment
for the radiologist. The specimen was photographed,
prior and after inking, to allow audit of the quality of
surgery. For a good resection the mesorectum should be
smooth with no violation of the fat, good bulk to the
mesorectum anteriorly and posteriorly and the distal
margin should appear adequate with no coning near the
Figure 4 In this picture there are some examples of T4-stage lesion invading surrounding structures such as seminal vescicle (4a:
axial T2 TSE wi), left levator ani muscle (4b: coronal T2 TSE wi) and uterus (4c: sagittal T2 TSE wi).
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or 5 mm deep. Then the specimen was opened down to
just above the tumour, but not through the tumour
which was kept untouched to preserve assessment of
the anterior aspect where CRM or peritoneal involve-
ment may be seen. Anterior and posterior non-perito-
nealised surfaces were painted with ink.
After the resection surfaces were inked the specimen
was fixed in formalin for a minimum of 3 days (72
hours). Good fixation allows thinner slices to be taken
and thus a better assessment of tumour spread. The seg-
ment of the fixed specimen containing the tumour was
then sectioned transversely at 5 mm intervals from 2 cm
below to 2 cm above the tumour itself, producing slices
that corresponded precisely to the MR sections.
Finally each slice was photographed and whole-mount
histopathologic slices were cut and stained with hema-
toxylin-eosin. The extent of local tumor spread in each
histopathologic slice was then assessed according to the
TNM staging.
The local lymph nodes were identified and embedded,
as should all the lymph nodes above and below the
tumour.
The circumferential margin was considered involved if
the tumour extended to within 1 mm of the circumfer-
ential excision margin.
Results
The whole MR examination time was about 20 minutes,
depending on the length of the tumour, and it was
always well tolerated. Each MR image was interpreted
by two experienced readers independently. The tumour,
the layers of the rectal wall, the perirectal tissues and
the mesorectal fascia were always well visualized in all
patients (n = 96).
The zonal anatomy of the rectal wall was best appre-
ciated on thin-section axial images where the three dif-
ferent layers may be easily recognized: the inner
hypointense and hyperintense layers respectively repre-
sent mucosa and submucosa, while the hypointense
inner and outer layers represent the muscolaris propria
characterized by the inner circular muscle and the outer
longitudinal muscle; the external hyperintense layer
represents perirectal fat tissue (Figure 5).
Even very thin hypointense structures such as the
mesorectal fascia was always identified independent of
the body habitus of the patient, owing to the high con-
trast between the hypointense fascia and the hyperin-
tense fat tissue in and outside the mesorectum.
Rectal carcinoma appeared as a higher signal intensity
structure than rectal wall in all T2-weighted sequences
so the infiltration was well appreciated thanks to the
contrast between high-intermediate signal intensity of
tumour and low signal intensity of surrounding muscle
tissues. The fat tissue remained high in signal intensity
and in this way, the tumour contrasted well also with
the surrounding fat tissue (Figure 6).
Moreover, the major anatomic structures such as the
levator ani muscle, the puborectal muscle, the internal
and external anal sphincters, and the anal canal were
easily evaluated (Figure 7a-b).
In the first group of pts MR demonstrated high accu-
racy in the prediction of correct T stage achieving an
agreement rate with histology of 95%: in 2 cases, MRI
overstaged attributing a T3 stage rather than a T2
(Table 1). Also for the identification of nodal disease (N
stage) our diagnosis agreed accurately with histological
data (94%) since MRI correctly assigned the N stage in
45/48 cases: in 2 patients MRI attributed a N1 stage
while the histology did not confirm nodal disease; in 1
case MRI revealed no evidence of nodal involvement
while histology reported N1 (Table 2) (Figure 8a-f).
MRI with phased-array coil showed high accuracy in
prediction of a tumour-involved MRF (MRF+) with a
sensibility and a specificity of 100% (Table 3) (Figure 9a-
c).
Preoperative chemo-radiotherapy was administered to
patients belonging to group II with locally advanced rec-
tal cancer and then treated with TME. Locally advanced
rectal cancer was defined as tumour extension through
the bowel wall, based on clinical and MR evaluation,
without associated distant metastases.
Figure 5 Axial T2 TSEwi shows the three different layers of
rectal wall: the inner hypointense and hyperintense layers
respectively represent mucosa (M) and submucosa (SM), the
hypointense inner and outer layers represent the muscolaris
propria (MP) characterized by the inner circular muscle (CM)
and the outer longitudinal muscle (LM); the external
hyperintense layer represents perirectal fat tissue (P) while the
internal the lumen (L).
Giusti et al. Radiation Oncology 2012, 7:29
http://www.ro-journal.com/content/7/1/29
Page 5 of 10In this second group population of patients submitted
to neoadjuvant therapy MRI correctly assigned tumour
stage (T) in 36/48 cases with 75% of agreement with the
histological results. In 12 cases MRI overstaged: 2
patients were staged as T2 rather than T1; 8 cases were
staged as T3 rather than T2; 2 lesions were classified as
T4 but resulted T3 at histology (Table 4).
MRI showed a sensibility of 100% and a specificity of
67% in prediction of a tumour-involved MRF (MRF+) as
shown in table 5.
For nodal metastasis (N stage) MRI showed 92% accu-
racy with 2 cases of overstaging ( N1 stage rather than
N0) and in 1 case MRI did not reveal any nodal involve-
ment whereas histology reported N1 (Table 6).
Moreover, in this second group of patients phased-array
MRI assessed also the treatment outcome. In fact, 22/48
cases resulted downstaged: 2 rectal cancer staged as T4 at
preoperative MR became T3 lesions after chemoradiation;
14 cases staged as T3 have became T2 (Figure 10); 4 case
staged as T3 downstaged to T1 and 2 cases staged as T2
resulted T1 at the end of the treatment.
Discussions
Our study demonstrated the high accuracy of preopera-
tive MRI in the prediction of correct T stage; the
Figure 6 Axial T2 TSEwi demonstrates a T2-stage rectal cancer
bounded by the mesorectal fat and the mesorectal fascia; in
particular the latter structure is appreciated on T2wi as a fine
line of low signal intensity (black arrows). In a TME the
mesorectal fascia correspond to the CRM.
Figure 7 These pictures show the normal rectal anatomy and the major anatomic structures such as the elevator ani muscle (EAM),
the puborectal muscle (PRM), the internal and external anal sphincters, the ischio-rectal fossa (IRF) and the anal canal, easily
evaluated on coronal T2 TSEwi (7a) and sagittal T2 TSEwi (7b).
Table 1 This table shows the high accuracy of MR
examination to predict the correct T stage
AP T1 T2 T3 T4 TOT
MR
T1 6 000 6
T2 0 10 00 1 0
T3 02 30 03 2
T4 00 0 0 0
TOT 61 23 0046/48
In 2 cases, MR overstaged the lesions attributing a T3 stage rather than a T2.
The agreement rate with histology was 95%.
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related with the data reported in the most of the studies
published in literature (65%-100%) [12-16].
For T staging, results of accuracy of phased-array coil
have been demonstrated to be similar to those obtained
with an endorectal coil, but with the advantage that also
nodal staging and a detailed imaging of all anatomical
structures above the pelvic floor is possible.
Moreover, there is no patient discomfort because no
insertion of any rectal coil is needed: the patient have
merely just to lie on the MR table and his/her comfort
is further enhanced in our technique by using the feet-
first supine position, resulting in fewer problems with
claustrophobia.
MRI demonstrated high performance also to assign
the correct tumour stage of small lesions confined to
rectal wall: T1 (16/20) and T2 (18/28).
The most frequent diagnostic error caused by MRI
consisted in correctly differentiated T2 from early T3
lesions: this overstaging was often caused by the pre-
sence of desmoplastic reaction within the peritumoral
tissues that made difficult the MR differentiation
between perirectal fat spiculation, caused by fibrosis
alone from those containing viable tumour cells.
The major problems occurred when MRI was per-
formed after neoadjuvant therapy because the agree-
ment rate with histhological results comes down from
95 to 75% due to post-radiation oedema, inflammation,
fibrosis and necrosis that made difficult a correct
diagnosis.
Table 2 MRI correctly assigned the N stage in 45/48
cases: in 2 patients MRI attributed a N1 stage while the
histology did not confirm nodal disease; in 1 case MRI
revealed no evidence of nodal involvement while
histology reported N1
AP N0 N1 N2 N3 TOT
MR
N0 22 1002 3
N1 2 13 001 5
N2 0010 01 0
N3 0000 0
TOT 24 14 10 0 45/48
Agreement rate with histology resulted being 94%.
Figure 8 In this picture it is represented on axial T2 TSE wi (8a) a T3-stage lesion infiltrating anterior rectal wall and perirectal fat;
within mesorectum it is possible to appreciate multiple lymphnodes (white arrows in 8a-c). The hystolopathological slides (8d-e) and the
corresponding slices of the gross specimen show the exact correlation with MR findings.
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sion, MRI was extremely accurate achieving a sensibility
and a specificity of 100% in the first group. Also for this
aspect our results were in accordance with those pub-
lished in literature, but decreased after neoadjuvant
therapy (II group) (specificity, 67%).
A recent Dutch study introduced a profile very similar
to our study as far as concerns the population of
patients that performed neoadjuvant therapy (48/96);
our data were indeed comparable with those (sensibility
of 100%, specificity of 32-59%): in both cases the lowest
values of specificity came from the overstaging. In the
most of patients when disease was overstaged at MRI, a
diffuse hypointense tissue infiltrating MRF, corre-
sponded to sterilized areas of fibrosis at histological ana-
lysis. Indeed postchemoradiation MRI was not able to
discriminate between the fibrotic spiculations in the
perirectal fat and spiculations with contextually malig-
nant cells at histological analysis [17].
The performances of MRI in the local staging of rectal
c a n c e rd i s e a s ec o n f i r mt h ep o s s i b i l i t yo ft h i st e c h n i q u e
to discriminate patients candidated to preoperative
neoadjuvant therapy especially considering the high per-
formances of MRI in defining MRF involvement. A
recent trial reported that, in selected patients, with FMR
+ at the moment of the diagnosis, the use of the preo-
perative radiation therapy is mandatory because reduces
the recurrence rate from 8.2% to 2.4% to 2 years [18].
In our experience, radiologist can be sure that the
MRF will be free, only when an intact rectal wall is
detected.
In this respect, the present T-staging system have its
shortcomings because it does not discriminate between
cancers with a wide FMR and cancers with a close or
involved FMR. Although most of those tumours are
classified as stage T3, they have a different risk of local
recurrence. In fact today it’s unanimously agreed that
the distance of the cancer from the CRM, represented
by the MRF, is a more powerful predictor for the local
recurrence rate, much more significant than the T stage.
In particular, if the distance of the tumour from MRF is
≥ 5 mm, radiologist may consider the fascia uninvolved;
if the distance is 2-5 mm the involvement is considered
border-line; if it is ≤ 1 mm, MRF is involved.
As regard N stage, identification of nodal disease is
still a diagnostic problem for the radiologist. Despite the
identification of lymph nodes as small as 2-3 mm on
high-spatial-resolution images, reliable detection of
nodal metastasis presently is not possible. The radiolo-
gist assessment of nodal involvement generally relies on
morphologic criteria such as the size and shape of the
node. The problem with morphologic imaging, however,
Table 3 The table shows the high accuracy of MR in
prediction the involvement of mesorectal fascia (MRF+):
sensitivity and specificity resulted both 100%
AP MRF+ MRF- TOT
MR
MRF+ 4 04
MRF- 0 44 44
TOT 44 4 4 8
Figure 9 In this picture there are represented different causes of mesorectal fascia infiltration: due to lymphangitic spread (9a); due
to T3-tumour involving circumferential resection margin (9b); due to lymphnodes located within 1 mm of the mesorectal fascia (9c).
In particular, this last case suggest that whenever there are lymphnodes located strictly near the mesorectal fascia, especially when they are
large, we need to report this because the circumferential resection margin may be involved.
Table 4 The table shows that MR correctly assigned
tumour stage in 36/48 cases with 75% of agreement with
the histological results
AP T1 T2 T3 T4 TOT
MR
T1 1 0 0001 0
T2 2 8 001 0
T3 0814 02 2
T4 0024 6
TOT 12 16 16 4 36/48
12 cases were overstaged: 2 patients were staged as T2 rather than T1; 8
cases were staged as T3 rather than T2; 2 lesions were classified as T4 but
resulted T3 at histology.
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between reactive and metastatic nodes, and with small
nodes micrometastases are easily missed. An additional
problem in rectal cancer is the high frequency of micro-
metastases in normal-sized nodes. In fact, there is cur-
rently no consensus about lymph node size vis-à-vis
nodal involvement: some authors report any detectable
lymph node, whereas others report only those lymph
nodes that are larger than a given size (3 mm, 5 mm, or
10 mm) [19].
In our study nodal evaluation had been estimated with
dimensional cut-off of 10 mm achieving an agreement
rate with histology of 96% that was comparable with the
values of literature but it is obvious that also our
approach has been arbitrary.
However, results of early anatomic studies showed
that over half of the metastatic nodes were within 3 cm
of the primary tumour and were smaller than 5 mm in
size [20-25]; these data evidently call in question the
real validity of the dimensional criteria.
Our experience has confirmed that MR with phased-
array coil is the technique of choice in the preoperative
local staging of rectal cancer since it helps to estimate
in a detailed and non-invasive way the entire mesorectal
fat and all the surrounding pelvic structures, MRF
included; moreover, it allows to identify the different
risk group of patients helping to decide about the treat-
ment and its outcome (downstaging with complete or
incomplete response), and finally to optimize a complete
excision allowing to those patients with an advantaced
rectal cancer to benefit from a sphincter-preserving
surgery.
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Table 5 The table shows the high accuracy (92%) of MR
for nodal metastasis: 2 cases were overstaged ( N1 stage
rather than N0) and 1 in case MR did not reveal any
nodal involvement whereas histology reported N1
AP N0 N1 N2 N3 TOT
MR
N0 22 1002 3
N1 2 13 001 5
N2 0010 01 0
N3 0000 0
TOT 24 14 10 0 45/48
Table 6 The table show the high sensitivity (100%) and
specificity (67%) of MR in predicting MRF+
AP MRF+ MRF- TOT
MR
MRF+ 12 12 24
MRF- 0 24 24
TOT 12 36 48
Figure 10 This picture shows a T3 tumour infiltrating the rectal wall and perirectal fat, with some irregular and heterogeneous lymph
nodes within the mesorectum. After neo-adjuvant therapy there is an evident tumour regression without any invasion into the surrounding
tissues as demonstrating by the gross specimen, where only a gelatinous mash has remained inside the rectal wall, and by the corresponding
histological slice where any evidence of extraluminal infiltration is present anymore.
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